VANOS Cream and Skin Barrier Function

NCT00819507 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Fluocinonide

Sponsor

Oregon Health and Science University

Collaborators

[object Object]